Woodline Partners’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Woodline Partners’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-122,191	Closed	-$91.1K	–	1066
2024 Q4	$91.1K	Buy	+122,191	New	+$122K	﹤0.01%	914

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Woodline Partners's OMGA Position: Q1 2025 in Review

Woodline Partners sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 122,191 shares — an estimated $91.1K sold.

Woodline Partners first reported a position in OMGA in Q4 2024 and held it in 1 quarter. The position peaked at $91.1K in Q4 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Woodline Partners reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Woodline Partners sold 122,191 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $91.1K.
Woodline Partners first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
Woodline Partners's Omega Therapeutics, Inc. Common Stock position peaked at $91.1K in Q4 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Woodline Partners's 13F filing for Q1 2025, filed 15 May 2025.